Skip to content
naulon
Not checkedNot checked for notices yet.

QSPR Modeling with Topological Indices of Some Potential Drug Candidates against COVID-19

Özge Çolakoğlu

Journal of Mathematics · 2022

doi:10.1155/2022/3785932 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

COVID‐19, which has spread all over the world and was declared as a pandemic, is a new disease caused by the coronavirus family. There is no medicine yet to prevent or end this pandemic. Even if existing drugs are used to alleviate the pandemic, this is not enough. Therefore, combinations of existing drugs and their analogs are being studied. Vaccines produced for COVID‐19 may not be effective for new variants of this virus. Therefore, it is necessary to find the drugs for this disease as soon as possible. Topological indices are the numerical descriptors of a molecular structure obtained by the molecular graph. Topological indices can provide information about the physicochemical properties and biological properties of molecules in the quantitative structure‐property relationship (QSPR) and quantitative structure‐activity relationship (QSAR) studies. In this paper, some analogs of lopinavir, favipiravir, and ritonavir drugs that have the property of being potential drugs against COVID‐19 are studied. QSPR models are studied using linear and quadratic regression analysis with topological indices for enthalpy of vaporization, flash point, molar refractivity, polarizability, surface tension, and molar volume properties of these analogs.

Abstract licence: CC BY

References29

    29 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.